Ümit Topaloĝlu

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Clinical Sciences, Oncology +8

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

Jing Sun, Qulu Zheng, Vithal Madhira et al. · JAMA Internal Medicine · 2021 · 277 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Towards large-scale twitter mining for drug-related adverse events

Jiang Bian, Ümit Topaloĝlu, Fan Yu · 2012 · 254 citations

Computing, Health Informatics, Pharmacology +17

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial

Angela Alistar, Bonny Morris, Rodwige Desnoyer et al. · The Lancet Oncology · 2017 · 228 citations

Medicine, Oncology, Pharmacology +11

Dissecting intratumoral myeloid cell plasticity by single cell RNA‐seq

Qianqian Song, Gregory A. Hawkins, L. James Wudel et al. · Cancer Medicine · 2019 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17